Editor(s):
(1) Dr. Manabu Makinodan, Nara Medical University, Japan.
(2) Prof. (Dr.) Kashmira J. Gohil, Director/Dean, Anand College of Pharmacy, Sharda Group of Institutions (SGI), Agra, India.
(3) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.
Reviewers:
(1) Lennart Hardell, Örebro University Hospital, Sweden.
(2) P. Suresh, Pondicherry University, India.
Additional Reviewers:
(1) Jitendra Onkar Bhangale, SMT. N. M. Padalia Pharmacy College, India.
(2) Anísio Francisco Soares, Rural Federal University of Pernambuco, Brazil.
(3) Harchaoui hakim, University Ibn Tofail Kenitra, Morocco.
(4) Osvaldo Garrido-Acosta, Universidad Nacional Autonoma de Mexico, Mexico.
(5) Zhiqian Tong, Wenzhou Medical University China.
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.5/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Lennart Hardell, Sweden) | File 1 | NA
Stage 2 | Peer review report_2 (P. Suresh, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA
Stage 3 | Comment_Editor_3_v1 | File 1 | NA